Worth Asset Management LLC Raises Position in SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 285.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,431 shares of the exchange traded fund’s stock after buying an additional 9,946 shares during the period. SPDR S&P Biotech ETF comprises 0.7% of Worth Asset Management LLC’s portfolio, making the stock its 26th largest holding. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,125,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XBI. Axiom Investment Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $26,000. Financial Life Planners bought a new position in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $30,000. Finally, SHP Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $31,000.

SPDR S&P Biotech ETF Trading Up 1.9%

SPDR S&P Biotech ETF stock opened at $157.37 on Friday. SPDR S&P Biotech ETF has a 12 month low of $84.81 and a 12 month high of $165.71. The stock has a fifty day simple moving average of $148.00 and a two-hundred day simple moving average of $135.33. The firm has a market cap of $10.28 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.